Home > > Asia And Global Unit Dose Manufacturing Market- Size, Share, Growth Rate, and Forecast
TABLE OF CONTENTS CHAPTER 1: RESEARCH METHODOLOGY 1.1. Delivery Model 1.2. Hypothesis Creation 1.3. Revenue narrow down of Companies and in-depth interviews 1.4. Data Triangulation and Validation 1.5. About Us 1.6. Key market segments CHAPTER 2: PREMIUM INSIGHTS CHAPTER 3: ASIA UNIT DOSE MANUFACTURING MARKET 3.1. OVERVIEW 3.2. ASIA 3.2.1. ASIA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 3.2.2. ASIA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 3.2.3. ASIA UNIT DOSE MANUFACTURING MARKET, BY END-USE 3.2.4. ASIA UNIT DOSE MANUFACTURING MARKET, BY COUNTRY 3.2.4.1. CHINA 3.2.4.1.1. CHINA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 3.2.4.1.2. CHINA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 3.2.4.1.3. CHINA UNIT DOSE MANUFACTURING MARKET, BY END-USE 3.2.4.2. JAPAN 3.2.4.2.1. JAPAN UNIT DOSE MANUFACTURING MARKET, BY SOURCING 3.2.4.2.2. JAPAN UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 3.2.4.2.3. JAPAN UNIT DOSE MANUFACTURING MARKET, BY END-USE 3.2.4.3. SOUTH KOREA 3.2.4.3.1. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 3.2.4.3.2. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 3.2.4.3.3. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET, BY END-USE 3.2.4.4. INDIA 3.2.4.4.1. INDIA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 3.2.4.4.2. INDIA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 3.2.4.4.3. INDIA UNIT DOSE MANUFACTURING MARKET, BY END-USE 3.2.4.5. SINGAPORE 3.2.4.5.1. SINGAPORE UNIT DOSE MANUFACTURING MARKET, BY SOURCING 3.2.4.5.2. SINGAPORE UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 3.2.4.5.3. SINGAPORE UNIT DOSE MANUFACTURING MARKET, BY END-USE 3.2.4.6. REST OF ASIA 3.2.4.6.1. REST OF ASIA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 3.2.4.6.2. REST OF ASIA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 3.2.4.6.3. REST OF ASIA UNIT DOSE MANUFACTURING MARKET, BY END-USE CHAPTER 4: GLOBAL UNIT DOSE MANUFACTURING MARKET, BY SOURCING 4.1. OVERVIEW 4.2. IN-HOUSE 4.2.1. IN-HOUSE MARKET, BY REGION 4.2.1.1. NORTH AMERICA IN-HOUSE MARKET, BY COUNTRY 4.2.1.2. EUROPE IN-HOUSE MARKET, BY COUNTRY 4.2.1.3. ASIA IN-HOUSE MARKET, BY COUNTRY 4.2.1.4. MIDDLE EAST & AFRICA IN-HOUSE MARKET, BY COUNTRY 4.3. OUTSOURCING 4.3.1. OUTSOURCING MARKET, BY REGION 4.3.1.1. NORTH AMERICA OUTSOURCING MARKET, BY COUNTRY 4.3.1.2. EUROPE OUTSOURCING MARKET, BY COUNTRY 4.3.1.3. ASIA OUTSOURCING MARKET, BY COUNTRY 4.3.1.4. MIDDLE EAST & AFRICA OUTSOURCING MARKET, BY COUNTRY CHAPTER 5: GLOBAL UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 5.1. OVERVIEW 5.2. LIQUID UNIT DOSE 5.2.1. LIQUID UNIT DOSE MARKET, BY REGION 5.2.1.1. NORTH AMERICA LIQUID UNIT DOSE MARKET, BY COUNTRY 5.2.1.2. EUROPE LIQUID UNIT DOSE MARKET, BY COUNTRY 5.2.1.3. ASIA LIQUID UNIT DOSE MARKET, BY COUNTRY 5.2.1.4. MIDDLE EAST & AFRICA LIQUID UNIT DOSE MARKET, BY COUNTRY 5.3. SOLID UNIT DOSE 5.3.1. SOLID UNIT DOSE MARKET, BY REGION 5.3.1.1. NORTH AMERICA SOLID UNIT DOSE MARKET, BY COUNTRY 5.3.1.2. EUROPE SOLID UNIT DOSE MARKET, BY COUNTRY 5.3.1.3. ASIA SOLID UNIT DOSE MARKET, BY COUNTRY 5.3.1.4. MIDDLE EAST & AFRICA SOLID UNIT DOSE MARKET, BY COUNTRY 5.4. OTHER PRODUCTS 5.4.1. OTHER PRODUCTS MARKET, BY REGION 5.4.1.1. NORTH AMERICA OTHER PRODUCTS MARKET, BY COUNTRY 5.4.1.2. EUROPE OTHER PRODUCTS MARKET, BY COUNTRY 5.4.1.3. ASIA OTHER PRODUCTS MARKET, BY COUNTRY 5.4.1.4. MIDDLE EAST & AFRICA OTHER PRODUCTS MARKET, BY COUNTRY CHAPTER 6: GLOBAL UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.1. OVERVIEW 6.2. INDEPENDENT PHARMACIES 6.2.1. INDEPENDENT PHARMACIES MARKET, BY REGION 6.2.1.1. NORTH AMERICA INDEPENDENT PHARMACIES MARKET, BY COUNTRY 6.2.1.2. EUROPE INDEPENDENT PHARMACIES MARKET, BY COUNTRY 6.2.1.3. ASIA INDEPENDENT PHARMACIES MARKET, BY COUNTRY 6.2.1.4. MIDDLE EAST & AFRICA INDEPENDENT PHARMACIES MARKET, BY COUNTRY 6.3. LONG TERM CARE FACILITY 6.3.1. LONG TERM CARE FACILITY MARKET, BY REGION 6.3.1.1. NORTH AMERICA LONG TERM CARE FACILITY MARKET, BY COUNTRY 6.3.1.2. EUROPE LONG TERM CARE FACILITY MARKET, BY COUNTRY 6.3.1.3. ASIA LONG TERM CARE FACILITY MARKET, BY COUNTRY 6.3.1.4. MIDDLE EAST & AFRICA LONG TERM CARE FACILITY MARKET, BY COUNTRY 6.4. HOSPITALS 6.4.1. HOSPITALS MARKET, BY REGION 6.4.1.1. NORTH AMERICA HOSPITALS MARKET, BY COUNTRY 6.4.1.2. EUROPE HOSPITALS MARKET, BY COUNTRY 6.4.1.3. ASIA HOSPITALS MARKET, BY COUNTRY 6.4.1.4. MIDDLE EAST & AFRICA HOSPITALS MARKET, BY COUNTRY 6.5. OTHER END- USES 6.5.1. OTHER END- USES MARKET, BY REGION 6.5.1.1. NORTH AMERICA OTHER END- USES MARKET, BY COUNTRY 6.5.1.2. EUROPE OTHER END- USES MARKET, BY COUNTRY 6.5.1.3. ASIA OTHER END- USES MARKET, BY COUNTRY 6.5.1.4. MIDDLE EAST & AFRICA OTHER END- USES MARKET, BY COUNTRY TABLE 75. MIDDLE EAST & AFRICA OTHER END- USES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)LIST OF TABLES TABLE 01. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 02. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 03. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 04. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 05. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 06. ASIA UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($MILLION) TABLE 07. ASIA UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($MILLION) TABLE 08. ASIA UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($MILLION) TABLE 09. ASIA UNIT DOSE MANUFACTURING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 10. CHINA UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 11. CHINA UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 12. CHINA UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 13. JAPAN UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 14. JAPAN UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 15. JAPAN UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 16. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 17. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 18. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 19. INDIA UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 20. INDIA UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 21. INDIA UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 22. SINGAPORE UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 23. SINGAPORE UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 24. SINGAPORE UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 25. REST OF ASIA UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 26. REST OF ASIA UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 27. REST OF ASIA UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 28. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 29. IN-HOUSE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 30. NORTH AMERICA IN-HOUSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 31. EUROPE IN-HOUSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 32. ASIA IN-HOUSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 33. MIDDLE EAST & AFRICA IN-HOUSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 34. OUTSOURCING MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 35. NORTH AMERICA OUTSOURCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 36. EUROPE OUTSOURCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 37. ASIA OUTSOURCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 38. MIDDLE EAST & AFRICA OUTSOURCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 39. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 40. LIQUID UNIT DOSE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 41. NORTH AMERICA LIQUID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 42. EUROPE LIQUID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 43. ASIA LIQUID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 44. MIDDLE EAST & AFRICA LIQUID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 45. SOLID UNIT DOSE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 46. NORTH AMERICA SOLID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 47. EUROPE SOLID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 48. ASIA SOLID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 49. MIDDLE EAST & AFRICA SOLID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 50. OTHER PRODUCTS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 51. NORTH AMERICA OTHER PRODUCTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 52. EUROPE OTHER PRODUCTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 53. ASIA OTHER PRODUCTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 54. MIDDLE EAST & AFRICA OTHER PRODUCTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 55. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 56. INDEPENDENT PHARMACIES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 57. NORTH AMERICA INDEPENDENT PHARMACIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 58. EUROPE INDEPENDENT PHARMACIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 59. ASIA INDEPENDENT PHARMACIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 60. MIDDLE EAST & AFRICA INDEPENDENT PHARMACIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 61. LONG TERM CARE FACILITY MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 62. NORTH AMERICA LONG TERM CARE FACILITY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 63. EUROPE LONG TERM CARE FACILITY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 64. ASIA LONG TERM CARE FACILITY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 65. MIDDLE EAST & AFRICA LONG TERM CARE FACILITY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 66. HOSPITALS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 67. NORTH AMERICA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 68. EUROPE HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 69. ASIA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 70. MIDDLE EAST & AFRICA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 71. OTHER END- USES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 72. NORTH AMERICA OTHER END- USES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 73. EUROPE OTHER END- USES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 74. ASIA OTHER END- USES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 75. MIDDLE EAST & AFRICA OTHER END- USES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)LIST OF FIGURES CHAPTER 1: RESEARCH METHODOLOGY 1.1. Delivery Model 1.2. Hypothesis Creation 1.3. Revenue narrow down of Companies and in-depth interviews 1.4. Data Triangulation and Validation 1.5. About Us 1.6. Key market segments CHAPTER 2: PREMIUM INSIGHTS CHAPTER 3: ASIA UNIT DOSE MANUFACTURING MARKET 3.1. OVERVIEW 3.2. ASIA 3.2.1. ASIA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 3.2.2. ASIA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 3.2.3. ASIA UNIT DOSE MANUFACTURING MARKET, BY END-USE 3.2.4. ASIA UNIT DOSE MANUFACTURING MARKET, BY COUNTRY 3.2.4.1. CHINA 3.2.4.1.1. CHINA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 3.2.4.1.2. CHINA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 3.2.4.1.3. CHINA UNIT DOSE MANUFACTURING MARKET, BY END-USE 3.2.4.2. JAPAN 3.2.4.2.1. JAPAN UNIT DOSE MANUFACTURING MARKET, BY SOURCING 3.2.4.2.2. JAPAN UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 3.2.4.2.3. JAPAN UNIT DOSE MANUFACTURING MARKET, BY END-USE 3.2.4.3. SOUTH KOREA 3.2.4.3.1. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 3.2.4.3.2. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 3.2.4.3.3. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET, BY END-USE 3.2.4.4. INDIA 3.2.4.4.1. INDIA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 3.2.4.4.2. INDIA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 3.2.4.4.3. INDIA UNIT DOSE MANUFACTURING MARKET, BY END-USE 3.2.4.5. SINGAPORE 3.2.4.5.1. SINGAPORE UNIT DOSE MANUFACTURING MARKET, BY SOURCING 3.2.4.5.2. SINGAPORE UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 3.2.4.5.3. SINGAPORE UNIT DOSE MANUFACTURING MARKET, BY END-USE 3.2.4.6. REST OF ASIA 3.2.4.6.1. REST OF ASIA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 3.2.4.6.2. REST OF ASIA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 3.2.4.6.3. REST OF ASIA UNIT DOSE MANUFACTURING MARKET, BY END-USE CHAPTER 4: GLOBAL UNIT DOSE MANUFACTURING MARKET, BY SOURCING 4.1. OVERVIEW 4.2. IN-HOUSE 4.2.1. IN-HOUSE MARKET, BY REGION 4.2.1.1. NORTH AMERICA IN-HOUSE MARKET, BY COUNTRY 4.2.1.2. EUROPE IN-HOUSE MARKET, BY COUNTRY 4.2.1.3. ASIA IN-HOUSE MARKET, BY COUNTRY 4.2.1.4. MIDDLE EAST & AFRICA IN-HOUSE MARKET, BY COUNTRY 4.3. OUTSOURCING 4.3.1. OUTSOURCING MARKET, BY REGION 4.3.1.1. NORTH AMERICA OUTSOURCING MARKET, BY COUNTRY 4.3.1.2. EUROPE OUTSOURCING MARKET, BY COUNTRY 4.3.1.3. ASIA OUTSOURCING MARKET, BY COUNTRY 4.3.1.4. MIDDLE EAST & AFRICA OUTSOURCING MARKET, BY COUNTRY CHAPTER 5: GLOBAL UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 5.1. OVERVIEW 5.2. LIQUID UNIT DOSE 5.2.1. LIQUID UNIT DOSE MARKET, BY REGION 5.2.1.1. NORTH AMERICA LIQUID UNIT DOSE MARKET, BY COUNTRY 5.2.1.2. EUROPE LIQUID UNIT DOSE MARKET, BY COUNTRY 5.2.1.3. ASIA LIQUID UNIT DOSE MARKET, BY COUNTRY 5.2.1.4. MIDDLE EAST & AFRICA LIQUID UNIT DOSE MARKET, BY COUNTRY 5.3. SOLID UNIT DOSE 5.3.1. SOLID UNIT DOSE MARKET, BY REGION 5.3.1.1. NORTH AMERICA SOLID UNIT DOSE MARKET, BY COUNTRY 5.3.1.2. EUROPE SOLID UNIT DOSE MARKET, BY COUNTRY 5.3.1.3. ASIA SOLID UNIT DOSE MARKET, BY COUNTRY 5.3.1.4. MIDDLE EAST & AFRICA SOLID UNIT DOSE MARKET, BY COUNTRY 5.4. OTHER PRODUCTS 5.4.1. OTHER PRODUCTS MARKET, BY REGION 5.4.1.1. NORTH AMERICA OTHER PRODUCTS MARKET, BY COUNTRY 5.4.1.2. EUROPE OTHER PRODUCTS MARKET, BY COUNTRY 5.4.1.3. ASIA OTHER PRODUCTS MARKET, BY COUNTRY 5.4.1.4. MIDDLE EAST & AFRICA OTHER PRODUCTS MARKET, BY COUNTRY CHAPTER 6: GLOBAL UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.1. OVERVIEW 6.2. INDEPENDENT PHARMACIES 6.2.1. INDEPENDENT PHARMACIES MARKET, BY REGION 6.2.1.1. NORTH AMERICA INDEPENDENT PHARMACIES MARKET, BY COUNTRY 6.2.1.2. EUROPE INDEPENDENT PHARMACIES MARKET, BY COUNTRY 6.2.1.3. ASIA INDEPENDENT PHARMACIES MARKET, BY COUNTRY 6.2.1.4. MIDDLE EAST & AFRICA INDEPENDENT PHARMACIES MARKET, BY COUNTRY 6.3. LONG TERM CARE FACILITY 6.3.1. LONG TERM CARE FACILITY MARKET, BY REGION 6.3.1.1. NORTH AMERICA LONG TERM CARE FACILITY MARKET, BY COUNTRY 6.3.1.2. EUROPE LONG TERM CARE FACILITY MARKET, BY COUNTRY 6.3.1.3. ASIA LONG TERM CARE FACILITY MARKET, BY COUNTRY 6.3.1.4. MIDDLE EAST & AFRICA LONG TERM CARE FACILITY MARKET, BY COUNTRY 6.4. HOSPITALS 6.4.1. HOSPITALS MARKET, BY REGION 6.4.1.1. NORTH AMERICA HOSPITALS MARKET, BY COUNTRY 6.4.1.2. EUROPE HOSPITALS MARKET, BY COUNTRY 6.4.1.3. ASIA HOSPITALS MARKET, BY COUNTRY 6.4.1.4. MIDDLE EAST & AFRICA HOSPITALS MARKET, BY COUNTRY 6.5. OTHER END- USES 6.5.1. OTHER END- USES MARKET, BY REGION 6.5.1.1. NORTH AMERICA OTHER END- USES MARKET, BY COUNTRY 6.5.1.2. EUROPE OTHER END- USES MARKET, BY COUNTRY 6.5.1.3. ASIA OTHER END- USES MARKET, BY COUNTRY 6.5.1.4. MIDDLE EAST & AFRICA OTHER END- USES MARKET, BY COUNTRY TABLE 01. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 02. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 03. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 04. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 05. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 06. ASIA UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($MILLION) TABLE 07. ASIA UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($MILLION) TABLE 08. ASIA UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($MILLION) TABLE 09. ASIA UNIT DOSE MANUFACTURING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 10. CHINA UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 11. CHINA UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 12. CHINA UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 13. JAPAN UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 14. JAPAN UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 15. JAPAN UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 16. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 17. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 18. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 19. INDIA UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 20. INDIA UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 21. INDIA UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 22. SINGAPORE UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 23. SINGAPORE UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 24. SINGAPORE UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 25. REST OF ASIA UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 26. REST OF ASIA UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 27. REST OF ASIA UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 28. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 29. IN-HOUSE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 30. NORTH AMERICA IN-HOUSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 31. EUROPE IN-HOUSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 32. ASIA IN-HOUSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 33. MIDDLE EAST & AFRICA IN-HOUSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 34. OUTSOURCING MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 35. NORTH AMERICA OUTSOURCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 36. EUROPE OUTSOURCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 37. ASIA OUTSOURCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 38. MIDDLE EAST & AFRICA OUTSOURCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 39. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 40. LIQUID UNIT DOSE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 41. NORTH AMERICA LIQUID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 42. EUROPE LIQUID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 43. ASIA LIQUID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 44. MIDDLE EAST & AFRICA LIQUID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 45. SOLID UNIT DOSE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 46. NORTH AMERICA SOLID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 47. EUROPE SOLID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 48. ASIA SOLID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 49. MIDDLE EAST & AFRICA SOLID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 50. OTHER PRODUCTS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 51. NORTH AMERICA OTHER PRODUCTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 52. EUROPE OTHER PRODUCTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 53. ASIA OTHER PRODUCTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 54. MIDDLE EAST & AFRICA OTHER PRODUCTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 55. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 56. INDEPENDENT PHARMACIES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 57. NORTH AMERICA INDEPENDENT PHARMACIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 58. EUROPE INDEPENDENT PHARMACIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 59. ASIA INDEPENDENT PHARMACIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 60. MIDDLE EAST & AFRICA INDEPENDENT PHARMACIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 61. LONG TERM CARE FACILITY MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 62. NORTH AMERICA LONG TERM CARE FACILITY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 63. EUROPE LONG TERM CARE FACILITY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 64. ASIA LONG TERM CARE FACILITY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 65. MIDDLE EAST & AFRICA LONG TERM CARE FACILITY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 66. HOSPITALS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 67. NORTH AMERICA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 68. EUROPE HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 69. ASIA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 70. MIDDLE EAST & AFRICA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 71. OTHER END- USES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 72. NORTH AMERICA OTHER END- USES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 73. EUROPE OTHER END- USES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 74. ASIA OTHER END- USES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 75. MIDDLE EAST & AFRICA OTHER END- USES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)